Legend Biotech Corporation (ADR)

General ticker "LEGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $5.3B (TTM average)

Legend Biotech Corporation (ADR) does not follow the US Stock Market performance with the rate: -18.1%.

Estimated limits based on current volatility of 11.0%: low 28.32$, high 35.30$

Factors to consider:

  • Total employees count: 882 as of 2020
  • Current price 22.7% above estimated high
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [13.36$, 29.32$]
  • 2026-12-31 to 2027-12-31 estimated range: [13.72$, 28.88$]

Similar symbols

Short-term LEGN quotes

Long-term LEGN plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $285.14MM $627.24MM $1,028.90MM
Operating Expenses $724.63MM $930.48MM $1,165.40MM
Operating Income $-439.49MM $-303.24MM $-136.50MM
Non-Operating Income $-80.63MM $145.11MM $-146.10MM
Interest Expense $21.79MM $21.61MM $21.40MM
R&D Expense $382.22MM $413.54MM $414.70MM
Income(Loss) $-520.12MM $-158.13MM $-282.60MM
Taxes $0.00MM $0.00MM $14.20MM
Net Income(Loss)* $-518.25MM $-177.03MM $-296.02MM
Stockholders Equity $1,251.37MM $1,040.55MM $1,002.10MM
Inventory $19.43MM $23.90MM $32.00MM
Assets $1,848.61MM $1,670.15MM $1,733.70MM
Operating Cash Flow $-393.28MM $-144.03MM $-100.47MM
Capital expenditure $22.72MM $14.11MM $67.58MM
Investing Cash Flow $92.79MM $-850.54MM $711.48MM
Financing Cash Flow $791.49MM $5.70MM $-0.30MM
Earnings Per Share** $-2.94 $-0.97 $-1.61
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.